FDA approves first drug for Alexander disease
The FDA says Zanvastro is the first approved treatment for Alexander disease and the first therapy aimed at the protein buildup tied to the condition.
AtlasWatchline Author
Hagens Berman seeks Photronics investors for lead plaintiff role before Sept. 4 deadline
Hagens Berman says investors who bought Photronics shares during a stated class period may seek lead plaintiff appointment in a pending securities class action.
ThreatLocker recaps August research, $190M Series F and U.K. office plans
ThreatLocker published an August recap on Sept. 3 that highlighted research into AI security risks, ClickFix attacks and exposed infrastructure, while also noting a $190 million Series F round and U.K. expansion plans.
HelloNation article says Rochester businesses should weigh armed security by risk
The article features security expert Corey Wild of Armor Security and Protection Inc. and outlines situations where armed guards may fit a broader risk plan.
Frank R. Cruz says Datavault AI investors may seek lead plaintiff role in fraud suit
A PR Newswire notice says the Law Offices of Frank R. Cruz is contacting Datavault AI investors who allegedly suffered losses in an ongoing securities fraud class action.
Innventure investors face Oct. 27 deadline in securities class action notice
A PR Newswire notice says Innventure investors with losses may move to lead an ongoing securities fraud class action, with a lead-plaintiff deadline of Oct. 27, 2026.
Howard G. Smith seeks Fractyl Health investors for securities fraud class action
A law firm press release says investors in Fractyl Health, Inc. who lost money may contact the firm about an alleged securities fraud class action tied to Revita and REMAIN-1.